🇺🇸 FDA
Pipeline program

NaCl 0.9% solution

215344

Phase 2 small_molecule active

Quick answer

NaCl 0.9% solution for Meningitis, Meningococcal is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline Biologicals S.A.
Indication
Meningitis, Meningococcal
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials